#BEGIN_DRUGCARD DB02460

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
23599-55-5

# ChEBI_ID:
17926

# Chemical_Formula:
C45H60N4O14

# Chemical_IUPAC_Name:
3-[(1S,2S,3R,4R,8R,9R,14R,18S,19S)-9,14,18-tris(2-carboxyethyl)-3,8,19-tris(carboxymethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1^{2,5}.1^{7,10}.1^{12,15}]tricosa-5,7(22),10,12(21),15,17(20)-hexaen-4-yl]propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Hydrogenobyrinic Acid

# HET_ID:
COJ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C45H60N4O14/c1-21-36-24(10-13-30(52)53)41(3,4)28(47-36)18-27-23(9-12-29(50)51)43(6,19-34(60)61)39(46-27)22(2)37-25(11-14-31(54)55)44(7,20-35(62)63)45(8,49-37)40-26(17-33(58)59)42(5,38(21)48-40)16-15-32(56)57/h18,23-26,40,49H,9-17,19-20H2,1-8H3,(H,50,51)(H,52,53)(H,54,55)(H,56,57)(H,58,59)(H,60,61)(H,62,63)/b27-18-,36-21-,37-22-/t23-,24-,25-,26+,40-,42-,43+,44+,45+/m0/s1

# InChI_Key:
InChIKey=MYMATQFDUQLSCD-WEIZKHOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C06399

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2460

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
880.9763

# Molecular_Weight_Mono:
880.410602648

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1I1H

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.19

# Predicted_LogS:
-4.8

# Predicted_Water_Solubility:
1.43e-02 g/l

# Primary_Accession_No:
DB02460

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936392

# PubChem_Substance_ID:
46506147

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00986

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)CC[C@H]1\C2=C\C3=N\C(=C(C)/C4=N[C@@H]([C@@H](CC(O)=O)[C@]4(C)CCC(O)=O)[C@@]4(C)N\C(=C(C)/C(=N2)[C@]1(C)CC(O)=O)[C@H](CCC(O)=O)[C@@]4(C)CC(O)=O)\[C@H](CCC(O)=O)C3(C)C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:10 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M59301

# Drug_Target_1_GenBank_ID_Protein:
151173

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cobH

# Drug_Target_1_Gene_Sequence:
>633 bp
ATGCCTGAGTATGATTACATTCGCGATGGCAACGCCATCTACGAGCGTTCCTTCGCCATC
ATCCGCGCCGAGGCCGATCTGTCGCGCTTCTCCGAAGAGGAAGCGGATCTGGCTGTGCGC
ATGGTGCACGCCTGCGGTTCCGTCGAGGCGACCAGGCAGTTCGTGTTTTCTCCCGATTTC
GTAAGCTCGGCCCGTGCGGCGCTGAAAGCCGGTGCGCCGATCCTCTGCGATGCCGAGATG
GTTGCGCACGGTGTCACCCGCGCCCGTCTGCCGGCCGGCAACGAGGTGATCTGCACGCTG
CGCGATCCTCGCACGCCCGCACTTGCGGCCGAGATCGGCAACACCCGCTCCGCCGCAGCC
CTGAAGCTCTGGAGCGAGCGGCTGGCCGGTTCGGTGGTCGCGATCGGCAACGCGCCGACG
GCGTTGTTCTTCCTCTTGGAAATGCTGCGCGACGGCGCGCCGAAGCCGGCGGCAATCCTC
GGCATGCCCGTCGGTTTCGTCGGTGCGGCGGAATCGAAGGATGCGCTGGCCGAGAACTCC
TATGGCGTTCCCTTCGCCATCGTGCGCGGCCGCCTCGGCGGGAGTGCCATGACGGCGGCA
GCGCTTAACTCGCTCGCGAGGCCGGGCCTGTGA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
1732194	Thibaut D, Couder M, Famechon A, Debussche L, Cameron B, Crouzet J, Blanche F: The final step in the biosynthesis of hydrogenobyrinic acid is catalyzed by the cobH gene product with precorrin-8x as the substrate. J Bacteriol. 1992 Feb;174(3):1043-9.
2211521	Crouzet J, Cameron B, Cauchois L, Rigault S, Rouyez MC, Blanche F, Thibaut D, Debussche L: Genetic and sequence analysis of an 8.7-kilobase Pseudomonas denitrificans fragment carrying eight genes involved in transformation of precorrin-2 to cobyrinic acid. J Bacteriol. 1990 Oct;172(10):5980-90.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3305

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
22065

# Drug_Target_1_Name:
Precorrin-8X methylmutase

# Drug_Target_1_Number_of_Residues:
210

# Drug_Target_1_PDB_ID:
1I1H

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02570	CbiC

# Drug_Target_1_Protein_Sequence:
>Precorrin-8X methylmutase
MPEYDYIRDGNAIYERSFAIIRAEADLSRFSEEEADLAVRMVHACGSVEATRQFVFSPDF
VSSARAALKAGAPILCDAEMVAHGVTRARLPAGNEVICTLRDPRTPALAAEIGNTRSAAA
LKLWSERLAGSVVAIGNAPTALFFLLEMLRDGAPKPAAILGMPVGFVGAAESKDALAENS
YGVPFAIVRGRLGGSAMTAAALNSLARPGL

# Drug_Target_1_Reaction:
precorrin-8X = hydrogenobyrinate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the conversion of precorrin-8X to hydrogenobyrinic acid; a methyl migration reaction during the transformation of precorrin-3 to form cobyrinic acid

# Drug_Target_1_SwissProt_ID:
P21638

# Drug_Target_1_SwissProt_Name:
COBH_PSEDE

# Drug_Target_1_Synonyms:
EC 5.4.1.2
HBA synthase
Precorrin isomerase

# Drug_Target_1_Theoretical_pI:
5.83

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02460
